The Use of Genomic Tests for Identifying Patients with Early Stage ILC Who Will Benefit from Chemo

แชร์
ฝัง
  • เผยแพร่เมื่อ 18 ธ.ค. 2024

ความคิดเห็น • 2

  • @nickylee1408
    @nickylee1408 2 ปีที่แล้ว +1

    I had lobular breast cancer dec 2011,stage 3 grade 3

  • @gregoryramsey8213
    @gregoryramsey8213 2 ปีที่แล้ว +2

    My gf has stage 2a breast cancer, Er+/HER-2 negative, with three positive lymph nodes with high percentages of estrogen and progesterone. She is 37, has oncotype score of 6, distant reoccurrence score at 11%, with no apparent benefit with chemo. Her ki67 is 7% and her blood work is 19 U/mL. She is planning on doing ovarian suppression. She is grade 2. She had nipple reserving double mastectomy. She’s very healthy. Her mother and grandmother had breast cancer. I know chemo suppresses ovaries (and helps by 5%), but she doesn’t want it. Would adjuvant endocrine therapy be recommended on these results?